Glucose Health Strengthens Its Board
Glucose Health, Inc. today announced the appointment of Christopher J. Jemapete to its Board of Directors. His addition comes at a significant time for the company as it looks to enhance its operational capabilities and market presence.
Experience and Background
Mr. Jemapete brings over thirty years of invaluable experience from the financial services and securities industries. He has worked with renowned Wall Street firms such as E.F. Hutton and Fidelity Investments, providing a solid foundation for strategic decision-making.
Career Highlights
Mr. Jemapete concluded his professional journey at ALPS Distributors, Inc., where his expertise played a crucial role in managing complex financial operations. His retirement in 2010 marked a shift towards philanthropic activities, particularly focusing on investment opportunities in the micro-cap sector.
Commitment to Glucose Health
Since investing in Glucose Health, Inc. in 2017, Mr. Jemapete has shown unwavering commitment to the company. His substantial equity stake demonstrates his belief in the mission of providing functional food and beverage products to combat health challenges.
Investment Strategy
Mr. Jemapete has directly influenced the company by participating in its Private Placements, significantly contributing to raising essential capital of over $2 million since 2019. His insights into investment strategies are expected to bolster Glucose Health's growth trajectory.
Future Vision
In his new role, Mr. Jemapete expressed a clear vision for the company's future, stating that securing adequate capital remains the central challenge. He highlighted the importance of expanding Glucose Health's retail distribution, particularly for its flagship products, GLUCODOWN® and FIBER UP®.
Retail Partnerships
Building on existing partnerships with major platforms like Amazon and leading pharmacy chains in the United States, Mr. Jemapete plans to focus on increasing revenue and shareholder value. He believes that with sufficient investment support, the company is poised for significant growth and community impact.
Educational Background
Mr. Jemapete holds a Bachelor of Science degree in Marketing from Fairfield University and is certified as a Financial Planner, reflecting his solid academic and professional foundation.
Contact Information
For inquiries, please reach out to Investor Relations at:
Investor Relations info@glucosehealthinc.com www.glucodown.com www.fiberup.com OTC: GLUC
Frequently Asked Questions
Who is Christopher J. Jemapete?
Christopher J. Jemapete is a finance expert recently appointed to Glucose Health, Inc.'s Board of Directors, bringing three decades of experience.
What is the role of Glucose Health, Inc.?
Glucose Health, Inc. focuses on creating functional food and beverage products to tackle obesity and diabetes issues.
What are GLUCODOWN® and FIBER UP®?
These are flagship products from Glucose Health designed to support health and wellness in managing glucose levels.
How can I contact Glucose Health, Inc.?
You can contact Glucose Health's Investor Relations via email at info@glucosehealthinc.com.
What is the significance of Mr. Jemapete's appointment?
Mr. Jemapete's appointment is expected to enhance strategic planning and investment opportunities for Glucose Health's growth.
